DCAT Value Chain Insights – Now a Podcast!
Podcast Recordings
Listen to specially selected articles from our website that feature in-depth analysis on the issues impacting the business of pharmaceutical development and manufacturing.
Blockbuster Muscle: Small Molecules or Biologics?
September 1, 2021
Which modality, small molecules or biologics, leads among the top-selling products? A look at the top-selling products industry-wide and blockbusters from select leading bio/pharma companies provides the answer.
This podcast is sponsored by: LGM Pharma
Injectable and Solid Dosage Drug Delivery: Key Deals
August 13, 2021
Drug delivery is important not only for ensuring bioavailability for therapeutic benefit but also for product differentiation and market success. DCAT Value Chain Insights highlights technology advances in drug delivery for injectable and solid-dosage drugs and other products from recent start-ups, partnering deals, and mergers and acquisitions.
This podcast is sponsored by: Vetter Pharma International GmbH
Mid-Year CDMO Review: COVID-19 Vaccine Manufacturing and M&A
June 9, 2021
What have been the key developments in 2021 thus far in the CDMO market? In this podcast we take a look at the increasing participation by CDMOs in COVID-19 vaccine manufacturing and robust mergers and acquisition activity that have marked the first half of 2021. What are the implications, and what can be expected going forward?
This podcast is sponsored by: Vetter Pharma International GmbH
FDA Addresses Supply Constraints Due to COVID-19; Plus, Packaging Suppliers Expand
March 10, 2021
In this podcast we take a look at the FDA’s new guidance to facilitate changes to container-closure-system components due to supply constraints, plus updates from suppliers of materials used to deliver COVID-19 vaccines, treatments and other parenteral drugs.
This podcast is sponsored by: Vetter Pharma International GmbH
The Year in Review: 2020
December 2, 2020
Although the COVID-19 pandemic dominated the headlines in 2020, there were other key developments in 2020. In this year in review, we look at the other key developments in 2020, including new product approvals, noteworthy deals, and other developments making the news.
This podcast is sponsored by: Vetter Pharma International GmbH
Company on the Move: Viatris
November 18, 2020
In this podcast we feature an article about what and who is behind Viatris, the new company formed from the combination of Upjohn, Pfizer’s off-patent branded and generic established medicines business, and Mylan.
This podcast is sponsored by: LabVantage Solutions
Solid-Dosage Mfg: CDMO Market and Product Trends
November 4, 2020
In this podcast we feature an article that looks at solid dosage manufacturing in terms of CDMO growth rates and recent product trends.
This podcast is sponsored by: Vetter Pharma International GmbH
Top 10 Watch List: Pharma CEOs on the Rise
October 21, 2020
In this podcast we feature a list of the Top 10 pharma CEOs to watch in 2020.
This podcast is sponsored by: LabVantage Solutions
The Pipeline Contenders: What Drugs Are Making the Mark?
October 7, 2020
In this podcast we feature a roundup of up expansions by CDMOs/CMOs and other suppliers in injectable drug development and manufacturing.
This podcast is sponsored by: Vetter Pharma International GmbH
Injectable Drugs: CDMOs/CMOs and Suppliers Expand
September 16, 2020
In this podcast we feature a roundup of up expansions by CDMOs/CMOs and other suppliers in injectable drug development and manufacturing.
This podcast is sponsored by: Vetter Pharma International GmbH